About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

NCT00228969·61 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

SK Life Science, Inc.

Age

18–79

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Age 18-70 years old,
2. Diagnosis of epilepsy for at least 1 year,
3. Presenting, on average, at least 3 partial onset seizures per month,
4. Currently treated with a stable dose (i.e., for at least 4 weeks) of no more than 3 anti-epileptic drugs (AEDs),

You may not be if

1. Have experienced status epilepticus in the past 3 months,
2. Have any serious diseases,
3. History of major psychiatric disorders within the past 2 years.
4. Have received an experimental drug/device within the past 30 days
5. Are pregnant or breastfeeding.

The record

StatusCompleted

PhasePhase 2

Taking part—

StartedFeb 2005

UpdatedAug 2, 2012

Conditions

Refractory Epilepsy

Where61

Birmingham, Alabama, United States
Huntsville, Alabama, United States
Mobile, Alabama, United States